Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Leukemia

  Free Subscription


10.11.2025

1 Am J Hematol
4 Ann Hematol
1 Biochem Pharmacol
2 Blood
1 BMC Cancer
2 Cancer
1 Cell
2 Eur J Haematol
1 Exp Hematol
1 Int J Hematol
1 J Clin Oncol
3 J Pediatr Hematol Oncol
3 Leuk Lymphoma
1 Leuk Res
5 Leukemia


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Hematol

  1. WANG WJ, Shen Q, Tashakori M, Fang H, et al
    Mixed-Phenotype Acute Leukemia With Mutated TP53: Genetic Landscape, Therapeutic Response, and Outcomes.
    Am J Hematol. 2025 Nov 6. doi: 10.1002/ajh.70133.
    PubMed        


    Ann Hematol

  2. PRAJAPATI S, Patel M, Jyotishi C, Gupta R, et al
    Phytochemicals in overcoming venetoclax resistance in acute myeloid leukemia: mechanistic insights and therapeutic potential.
    Ann Hematol. 2025 Nov 7. doi: 10.1007/s00277-025-06710.
    PubMed         Abstract available

  3. HORNAK T, Zackova D, Mayer J
    Potential differences between real-life and randomized controlled trial populations in chronic myeloid leukemia.
    Ann Hematol. 2025 Nov 5. doi: 10.1007/s00277-025-06703.
    PubMed        

  4. WANG X, Liu C, Chen Y, Wang J, et al
    Relapse risk and outcome of discontinuing asparaginase in children with acute lymphoblastic leukemia.
    Ann Hematol. 2025 Nov 4. doi: 10.1007/s00277-025-06682.
    PubMed         Abstract available

  5. PEI W, Duan Y, Jin L, Yang X, et al
    Analysis of the clinical characteristics and prognostic factors of multicenter childhood Burkitt leukemia.
    Ann Hematol. 2025 Nov 3. doi: 10.1007/s00277-025-06672.
    PubMed         Abstract available


    Biochem Pharmacol

  6. BACCI L, Pollutri D, Ripa IJ, D'Andrea M, et al
    Ribosomal protein L5 (RPL5/uL18) I60V mutation is associated to increased translation and modulates drug sensitivity in T-cell acute lymphoblastic leukemia cells.
    Biochem Pharmacol. 2025;243.
    PubMed         Abstract available


    Blood

  7. KAWANO G, Ikeda R, Ishihara D, Shima T, et al
    Guanine nucleotides drive ribosome biogenesis and glycolytic reprogramming in acute myeloid leukemia stem cells.
    Blood. 2025 Nov 5:blood.2025030209. doi: 10.1182/blood.2025030209.
    PubMed         Abstract available

  8. STELLJES M, Middeke JM, Bug G, Wagner-Drouet EM, et al
    Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial.
    Blood. 2025;146:2293-2305.
    PubMed         Abstract available


    BMC Cancer

  9. ERDEM S, Bayrak Tokac AG, Aday A, Karaca D, et al
    Pilot evaluation of optical genome mapping in chronic lymphocytic leukemia: complementing FISH analysis.
    BMC Cancer. 2025;25:1687.
    PubMed         Abstract available


    Cancer

  10. BAO M, Zhang XS, Li ZR, Yu L, et al
    Efficacy, safety and predictive biomarker of third-generation tyrosine kinase inhibitors with azacitidine in myeloid blast phase of chronic myeloid leukemia.
    Cancer. 2025;131:e70166.
    PubMed         Abstract available

  11. QIAN CS, Wang ZH, Li Z, Yao Z, et al
    A phase 2 trial of a "sandwich" strategy: Sequential CD22/CD19 chimeric antigen receptor T-cells therapy combined with autologous hematopoietic stem cell transplantation in patients with Philadelphia chromosome-negative B-cell acute lymphoblastic leuk
    Cancer. 2025;131:e70168.
    PubMed         Abstract available


    Cell

  12. DATAR GK, Khabusheva E, Anand A, Beale J, et al
    Disparate leukemia mutations converge on nuclear phase-separated condensates.
    Cell. 2025 Nov 4:S0092-8674(25)01149-3. doi: 10.1016/j.cell.2025.
    PubMed         Abstract available


    Eur J Haematol

  13. VIGNA E, Bruzzese A, Mule A, Sucato G, et al
    Real-World Evaluation of Oral Decitabine/Cedazuridine in Elderly Patients With Acute Myeloid Leukemia.
    Eur J Haematol. 2025 Nov 6. doi: 10.1111/ejh.70057.
    PubMed        

  14. TVEDT THA, Qvigstad C, Nezvalova-Henriksen K, Bergland BS, et al
    Three-Month Posttransplant Lipidomic Profile Reflects Acute GVHD but Not Chronic GVHD Risk in Allogeneic Stem Cell Recipients.
    Eur J Haematol. 2025;115:565-573.
    PubMed         Abstract available


    Exp Hematol

  15. VARGHESE P, Garcia-Cuellar MP, Slany RK
    The myeloid transcription factor Elf1 regulates genes with function in innate immunity.
    Exp Hematol. 2025;151:104864.
    PubMed         Abstract available


    Int J Hematol

  16. IMANAKA R, Numata H, Katsuoka Y, Uoshima N, et al
    Real-world outcomes of venetoclax and azacitidine in Japanese patients with newly diagnosed acute myeloid leukemia (VENUS study).
    Int J Hematol. 2025 Nov 7. doi: 10.1007/s12185-025-04093.
    PubMed         Abstract available


    J Clin Oncol

  17. WIEDUWILT MJ, Yin J, Kour O, Teske R, et al
    Inotuzumab Ozogamicin Then Blinatumomab for Older Adults With Newly Diagnosed B-Cell ALL: Alliance Study A041703 Cohort 1 Results.
    J Clin Oncol. 2025;43:3526-3535.
    PubMed         Abstract available


    J Pediatr Hematol Oncol

  18. KOBAYASHI K, Mizuta S, Ohashi Y, Yoshida S, et al
    Optimized Flow Cytometry Incorporating t-SNE Enables Minimal Residual Disease Assessment in a Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia at or Near the Lower Detection Limit.
    J Pediatr Hematol Oncol. 2025 Nov 5. doi: 10.1097/MPH.0000000000003142.
    PubMed         Abstract available

  19. CHERIYAN R, Kumar N, Vijayasekharan K, Rajeshwari B, et al
    Experimental Treatment of Measles Encephalitis With Inosine Pranobex and Remdesivir in a Child With Lymphocytic Leukemia.
    J Pediatr Hematol Oncol. 2025 Oct 30. doi: 10.1097/MPH.0000000000003141.
    PubMed         Abstract available

  20. HUANG B, Jia Y, Qi B, Wang H, et al
    KMT2A::NRIP3 Fusion Gene in the First Reported Case of B-Cell Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2025 Oct 31. doi: 10.1097/MPH.0000000000003137.
    PubMed         Abstract available


    Leuk Lymphoma

  21. SALTER B, Ge S, Garcia-Horton A, Berg T, et al
    Real-world experience and outcomes of decitabine/cedazuridine or azacitidine for the treatment of myelodysplastic syndrome/chronic myelomonocytic leukemia.
    Leuk Lymphoma. 2025 Nov 5:1-8. doi: 10.1080/10428194.2025.2577861.
    PubMed        

  22. NGO D, Kaleka G, Yang D, Mokhtari S, et al
    Real world outcomes of patients with secondary acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation after induction with liposomal daunorubicin-cytarabine (CPX-351).
    Leuk Lymphoma. 2025 Nov 5:1-4. doi: 10.1080/10428194.2025.2584682.
    PubMed        

  23. GOUZU Y, Ide Y, Shigeto S, Saito T, et al
    Chemotherapy-associated lineage shift of T/myeloid mixed-phenotype acute leukemia into AML-MRC: a case report.
    Leuk Lymphoma. 2025 Nov 5:1-5. doi: 10.1080/10428194.2025.2582716.
    PubMed        


    Leuk Res

  24. LI J, Shi S, Zhu K, Zhe L, et al
    IGF2BP3 promotes acute myeloid leukemia cell progression by regulating Semaphorin 4D stability in an m6A-dependent manner.
    Leuk Res. 2025;159:108119.
    PubMed         Abstract available


    Leukemia

  25. TEDESCHI A, Frustaci AM, Menna P, Minotti G, et al
    Correction: Fixed-duration therapy of chronic lymphocytic leukemia with venetoclax and Bruton tyrosine kinase inhibitors: an insight into differences between ibrutinib and acalabrutinib.
    Leukemia. 2025 Nov 3. doi: 10.1038/s41375-025-02793.
    PubMed        

  26. OHLSTROM D, Bakhtiari M, Mumme H, Michaud M, et al
    Longitudinal single-cell analysis reveals treatment-resistant stem and mast cells with potential treatments for pediatric AML.
    Leukemia. 2025;39:2721-2734.
    PubMed         Abstract available

  27. ZAZA A, Zardo G, Banella C, Tucci S, et al
    PML::RARalpha+ myeloid cells display metabolic alterations that can be targeted to treat resistant/relapse acute promyelocytic leukemias.
    Leukemia. 2025;39:2708-2720.
    PubMed         Abstract available

  28. PATEL SA, Bennett JM
    The evolving nosology of myeloid neoplasms: the semi-centennial of the 1976 French-American-British classification.
    Leukemia. 2025;39:2603-2609.
    PubMed         Abstract available

  29. ZIMOLOVA V, Burocziova M, Berkova L, Grusanovic S, et al
    Germline Jak2-R1063H mutation interferes with normal hematopoietic development and increases risk of thrombosis and leukemic transformation.
    Leukemia. 2025;39:2745-2757.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.